Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
(A joint stock limited company incorporated in the People's Republic of China with limited
liability and carrying on business in Hong Kong as 國控股份有限公司)
(Stock Code: 01099)
ANNOUNCEMENT
Pursuant to the rules of the National Association of Financial Market Institutional Investors and the Shanghai Stock Exchange, Sinopharm Group Co. Ltd. (the "Company") is required to publish the quarterly financial information of the Company and its subsidiaries (the "Group") which consists of consolidated balance sheet, consolidated income statement and consolidated cash flow statement of the Group, and to publish the quarterly financial information of the Company which consists of balance sheet, income statement and cash flow statement of the Company.
This announcement is made pursuant to Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) and Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The board of directors of the Company is pleased to announce the unaudited financial information of the Group and of the Company for the nine months ended 30 September 2019 prepared in accordance with the PRC GAAP.
- 1 -
CONSOLIDATED FINANCIAL INFORMATION OF THE GROUP
FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019
Consolidated Balance Sheet of the Group as at 30 September 2019
(All amounts in RMB unless otherwise stated)
As at | As at | ||
Items | 30 September 2019 | 31 December 2018 | |
Current assets: | |||
Cash at bank and on hand | 35,121,089,853.34 | 47,487,528,618.24 | |
Financial assets held for trading | 168,810.00 | 41,198,530.00 | |
Notes receivables | 1,594,863,721.24 | 4,257,138,963.27 | |
Accounts receivables | 142,715,762,934.24 | 96,601,274,662.65 | |
Accounts receivable financing | 6,495,466,843.12 | 5,565,180,501.19 | |
Advances to suppliers | 10,804,190,864.00 | 9,614,287,558.46 | |
Other receivables | 5,970,435,930.27 | 4,656,890,495.68 | |
Inventories | 45,478,266,553.45 | 35,003,521,705.93 | |
Contract assets | 256,660,236.28 | 250,294,490.79 | |
Current portion of non-current assets | 30,826,065.47 | 96,614,226.92 | |
Other current assets | 459,573,206.00 | 693,281,294.86 | |
Total current assets | 248,927,305,017.41 | 204,267,211,047.99 | |
Non-current assets: |
Long-term receivables Long-term equity investments
Equity investments designated at fair value through other comprehensive income
Other non-current financial assets Investment properties
Fixed assets Construction in progress Right-of-use assets Intangible assets Development costs Goodwill
Long-term prepaid expenses Deferred tax assets
Other non-current assets
Total non-current assets
1,901,719,978.98 1,928,460,253.20
6,814,005,374.00 6,382,066,834.49
32,233,059.7528,375,306.40
758,953,049.31654,671,911.19
981,992,420.81887,285,223.57
8,371,817,920.45 8,018,091,594.45
2,516,255,750.07 2,363,066,177.66
4,286,746,419.12-
4,078,356,643.03 3,890,900,152.15
60,336,477.5750,046,687.35
5,505,532,804.40 4,850,729,292.44
870,249,623.73767,864,418.15
1,259,334,069.88979,018,141.57
643,364,081.22559,492,165.33
38,080,897,672.32 31,360,068,157.95
Total assets | 287,008,202,689.73 | 235,627,279,205.94 | |
- 2 -
Consolidated Balance Sheet of the Group as at 30 September 2019 (continued)
(All amounts in RMB unless otherwise stated)
Items
Current liabilities: Short-termborrowings Notes payables Accounts payables Contract liabilities Employee benefits payable Taxes payable
Other payables
Current portion of non-current liabilities Other current liabilities
Total current liabilities
Non-current liabilities: Long-termborrowings Bonds payables
Lease liabilities Long-term payables
Long-term employee benefits payable Provisions
Deferred income Deferred tax liabilities Other non-current liabilities
Total non-current liabilities
Total liabilities
As at | As at |
30 September 2019 | 31 December 2018 |
38,554,757,769.58 31,840,935,666.48
24,153,205,182.13 19,197,920,568.54
80,097,884,386.10 64,485,006,710.90
7,094,777,531.60 6,101,607,127.18
1,155,100,374.99 1,380,337,062.48
1,694,301,060.64 2,061,429,077.23
23,020,834,595.23 16,543,403,811.64
1,525,917,558.85 4,471,456,225.19
21,014,012,886.95 13,993,421,372.39
198,310,791,346.07160,075,517,622.03
574,000,000.00657,310,000.00
8,831,688,486.42 4,293,856,833.50
2,886,452,697.25-
508,809,793.89208,139,938.58
84,064,165.8995,537,599.89
16,206,065.2717,140,427.88
372,443,305.60350,845,836.37
856,473,031.12864,905,946.02
625,709,266.32613,268,601.09
14,755,846,811.76 7,101,005,183.33
213,066,638,157.83167,176,522,805.36
- 3 -
Consolidated Balance Sheet of the Group as at 30 September 2019 (continued)
(All amounts in RMB unless otherwise stated)
As at | As at | |||
Items | 30 September 2019 | 31 December 2018 | ||
Owners' equity (or shareholders' equity): | ||||
Paid-in capital (or share capital) | 2,971,656,191.00 | 2,971,656,191.00 | ||
Capital surplus | 17,174,503,191.67 | 17,050,886,595.55 | ||
Less: treasury shares held for share incentive scheme | 135,317,558.39 | 135,317,558.39 | ||
Other comprehensive income | (7,213,992.37) | (3,288,793.12) | ||
Specific reserve | 1,090,863.31 | 1,145,336.11 | ||
Surplus reserve | 1,071,084,654.97 | 1,071,084,654.97 | ||
Undistributed profits | 24,824,430,373.41 | 21,982,464,277.25 | ||
Total shareholders' equity attributable to equity holders | ||||
of the Company | 45,900,233,723.60 | 42,938,630,703.37 | ||
Minority interest | 28,041,330,808.30 | 25,512,125,697.21 | ||
Total owners' equity (or shareholders' equity) | 73,941,564,531.90 | 68,450,756,400.58 | ||
Total liabilities and owners' equity | ||||
(or shareholders' equity): | 287,008,202,689.73 | 235,627,279,205.94 | ||
- 4 -
Consolidated Income Statement of the Group for the Nine Months Ended 30 September 2019
(All amounts in RMB unless otherwise stated)
Items
- Total operating revenue Including: Operating revenue
-
Total operating cost Including: Operating cost
Taxes and surcharges
Selling and distribution expenses General and administrative expenses Research and development expenses Financial expenses
Add: Other gains (loss shall be stated as "-")
Investment income (loss shall be stated as "-")
Profit arising from changes in fair value (loss
shall be stated as "-")
Credit impairment losses (loss shall be stated as "-")
Asset impairment losses (loss shall be stated as "-")
Gains on disposal of assets (loss shall be stated as "-")
- Operating profit (loss shall be stated as "-")
Add: Non-operating income
Less: Non-operating expenses
-
Total profit (total loss shall be stated as "-")
Less: Income tax expenses - Net profit (net loss shall be stated as "-")
Classification according to the continuity of operation Net profit from continuing operations
Net profit from discontinued operations Attributable to:
Net profit attributable to equity holders of the Company Net profit attributable to minority interest
6. Other comprehensive income/(loss), net of tax
Net other comprehensive income/(loss) attributable to equity holders of the company
Other comprehensive income/(loss) that will not be reclassified to profit or loss in subsequent periods
- 5 -
For the nine | For the nine |
months ended | months ended |
30 September 2019 | 30 September 2018 |
312,688,146,247.71 | 250,820,438,349.45 |
312,688,146,247.71 | 250,820,438,349.45 |
302,994,934,902.26 | 242,540,236,627.52 |
285,463,843,093.20 | 228,242,219,276.03 |
688,495,855.06 | 574,038,331.74 |
8,937,506,759.67 | 7,408,488,187.88 |
4,379,505,398.67 | 3,398,823,671.10 |
96,783,993.67 | 74,654,536.67 |
3,428,799,801.99 | 2,842,012,624.10 |
231,162,384.32 | 193,386,289.87 |
656,217,825.82 | 542,179,514.68 |
3,639,841.58 | 41,197,530.49 |
(660,886,641.60) | (549,599,263.60) |
(112,742,997.87) | (25,870,123.90) |
2,984,655.14 | 4,386,845.89 |
9,813,586,412.84 | 8,485,882,515.37 |
52,200,009.12 | 60,235,425.82 |
47,930,450.10 | 45,118,892.51 |
9,817,855,971.86 | 8,500,999,048.68 |
2,207,405,668.79 | 1,916,816,994.40 |
7,610,450,303.07 | 6,584,182,054.28 |
7,610,450,303.07 | 6,584,182,054.28 |
- | - |
4,595,243,248.85 | 4,117,328,353.52 |
3,015,207,054.22 | 2,466,853,700.76 |
(2,621,457.62) | (15,385,096.25) |
(3,925,199.25) | (13,432,596.14) |
800,189.24 | (5,436,695.10) |
Consolidated Income Statement of the Group for the Nine Months Ended 30 September 2019 (continued)
(All amounts in RMB unless otherwise stated)
Items
Remeasurements of post-employment benefit obligations
Fair value losses on other equity instrument investments
Other comprehensive income/(loss) that may be reclassified to profit or loss in subsequent periods Other comprehensive income/(loss) using the equity
method that may be reclassified to profit or loss Exchange differences on translation of foreign
operations
Net profit/(loss) of other comprehensive income attributable to minority interest
7. Total comprehensive income
Total comprehensive income attributable to equity holders of the Company
Total comprehensive income attributable to minority interest
8. Earnings per share:
For the nine | For the nine |
months ended | months ended |
30 September 2019 | 30 September 2018 |
(677,904.41) | - |
1,478,093.65 | (5,436,695.10) |
(4,725,388.49) | (7,995,901.04) |
391,268.17 | (2,282,054.13) |
(5,116,656.66) | (5,713,846.91) |
1,303,741.63 | (1,952,500.11) |
7,607,828,845.45 | 6,568,796,958.03 |
4,591,318,049.60 | 4,103,895,757.38 |
3,016,510,795.85 | 2,464,901,200.65 |
Basic earnings per share | 1.55 | 1.49 |
Diluted earnings per share | 1.55 | 1.49 |
- 6 -
Consolidated Cash Flow Statement of the Group for the Nine Months Ended 30 September 2019
(All amounts in RMB unless otherwise stated)
Items
1. Cash flows from operating activities:
Cash received from sales of goods or rendering of services Refund of taxes and surcharges
Cash received relating to other operating activities
Sub-total of cash inflows from operating activities
Cash paid for goods and services
Cash paid to and on behalf of employees
Payments of taxes and surcharges
Cash paid relating to other operating activities
For the nine | For the nine | |
months ended | months ended | |
30 September 2019 | 30 September 2018 | |
320,172,856,309.92 | 256,711,933,157.34 | |
106,271,885.61 | 105,460,951.08 | |
3,919,445,223.01 | 2,882,277,669.42 | |
324,198,573,418.54 | 259,699,671,777.84 | |
317,434,587,320.64 | 256,225,403,061.46 | |
7,363,701,179.50 | 6,137,084,353.46 | |
7,537,649,455.23 | 6,210,668,682.02 | |
7,427,531,547.52 | 5,150,908,141.03 |
Sub-total of cash outflows from operating activities | 339,763,469,502.89 | 273,724,064,237.97 | ||
Net cash flows used in operating activities | (15,564,896,084.35) | (14,024,392,460.13) | ||
2. | Cash flows from investing activities: | |||
Cash received from disposal of investments | 86,153,181.88 | 58,333,484.68 | ||
Cash received from returns on investments | 213,150,827.76 | 268,708,805.44 | ||
Net cash received from disposals of fixed assets, | ||||
intangible assets and other long-term assets | 100,962,150.17 | 61,541,381.76 | ||
Net cash received from disposal of subsidiaries | ||||
and other business units | (1,472,447.32) | (1,394,218.48) | ||
Cash received relating to other investing activities | 26,740,274.22 | - | ||
Sub-total of cash inflows from investing activities | 425,533,986.71 | 387,189,453.40 | ||
Cash paid to acquire fixed assets, intangible | ||||
assets and other long-term assets | 1,406,688,040.11 | 2,550,239,774.69 | ||
Cash paid to acquire investments | 231,259,837.91 | 368,799,400.00 | ||
Net cash paid to acquire subsidiaries | ||||
and other business units | 663,545,837.51 | 280,577,428.51 | ||
Cash paid relating to other investing activities | 849,882,333.84 | 608,342,361.68 | ||
Sub-total of cash outflows from investing activities | 3,151,376,049.37 | 3,807,958,964.88 | ||
Net cash flows used in investing activities | (2,725,842,062.66) | (3,420,769,511.48) | ||
- 7 - | ||||
Consolidated Cash Flow Statement of the Group for the Nine Months Ended 30 September 2019 (continued)
(All amounts in RMB unless otherwise stated)
For the nine | For the nine | ||
months ended | months ended | ||
Items | 30 September 2019 | 30 September 2018 | |
3. Cash flows from financing activities: | |||
Cash received from capital contributions | 800,667,517.00 | 612,613,632.00 | |
Cash received from borrowings | 73,150,363,093.59 | 68,161,449,787.61 | |
Cash received relating to other financing activities | 1,196,797,279.64 | 4,787,189,118.58 | |
Sub-total of cash inflows from financing activities | 75,147,827,890.23 | 73,561,252,538.19 | |
Cash repayments of borrowings | 62,689,632,933.62 | 50,749,845,891.22 | |
Cash payments for interest expenses and distribution of | |||
dividends or profits | 6,076,968,396.63 | 4,752,562,930.30 | |
Cash payments relating to other financing activities | 1,372,795,288.82 | 5,790,528,474.97 | |
Sub-total of cash outflows from financing activities | 70,139,396,619.07 | 61,292,937,296.49 | |
Net cash flows from financing activities | 5,008,431,271.16 | 12,268,315,241.70 | |
4. Effect of foreign exchange rate changes on cash and | |||
cash equivalents | 5,985,777.11 | (23,923,392.09) | |
5. Net decrease in cash and cash equivalents | (13,276,321,098.74) | (5,200,770,122.00) | |
Add: Cash and cash equivalents at the beginning of the | |||
reporting period | 40,298,985,123.85 | 32,249,947,148.88 | |
6. Cash and cash equivalents at the end of the reporting | |||
period | 27,022,664,025.11 | 27,049,177,026.88 | |
- 8 -
FINANCIAL INFORMATION OF THE COMPANY | ||||
FOR THE NINE MONTHS ENDED 30 SEPTEMBER | 2019 | |||
Balance Sheet of the Company as at 30 September 2019 | ||||
(All amounts in RMB unless otherwise stated) | ||||
As at 30 | As at 31 | |||
Items | September 2019 | December 2018 | ||
Current assets: | ||||
Cash at bank and on hand | 5,719,766,824.54 | 14,688,606,790.90 | ||
Notes receivables | 59,462,324.02 | 50,970,458.62 | ||
Accounts receivables | 3,066,347,886.29 | 1,999,942,234.96 | ||
Advances to suppliers | 47,138,387.16 | 62,935,702.07 | ||
Other receivables | 27,947,668,704.73 | 20,799,012,603.04 | ||
Inventories | 912,375,974.39 | 814,944,833.12 | ||
Total current assets | ||||
37,752,760,101.13 | 38,416,412,622.71 | |||
Non-current assets: |
Long-term equity investments Other non-current financial assets Investment properties
Fixed assets Construction in progress Intangible assets Long-term prepaid expenses Deferred tax assets
Other non-current assets
Total non-current assets
Total assets
30,882,198,549.30 30,156,315,186.29
597,409,092.96598,377,954.84
23,940,351.3524,688,738.70
44,137,747.3047,980,362.47
1,909,739,158.92 1,891,580,663.18
186,344,974.33211,445,280.12
2,159,873.103,078,480.36
72,516,958.6775,521,975.61
90,147,632.7260,880,747.55
33,808,594,338.65 33,069,869,389.12
71,561,354,439.78 71,486,282,011.83
- 9 -
Balance Sheet of the Company as at 30 September 2019 (continued)
(All amounts in RMB unless otherwise stated)
Items
Current liabilities:
Short-term borrowings Notes payables Accounts payables Contract liabilities Employee benefits payable Taxes payable
Other payables
Current portion of non-current liabilities Other current liabilities
As at | As at |
30 September 2019 | 31 December 2018 |
- 900,000,000.00
474,949,173.39 669,011,736.52
2,201,492,752.98 2,079,440,824.65
3,105,814.6631,407,888.47
46,599,933.4945,752,322.41
14,006,462.5128,541,176.25
12,462,214,112.59 18,506,583,343.96
- 3,997,636,558.98
20,491,132,642.91 13,992,337,000.89
Total current liabilities | 35,693,500,892.53 | 40,250,710,852.13 | |
Non-current liabilities: | |||
Bonds payables | 8,831,688,486.42 | 4,293,856,833.50 | |
Deferred income | 172,225.96 | 459,891.07 | |
Deferred Tax Liabilities | 22,796,546.27 | 23,241,371.27 | |
Other non-current liabilities | 864,072,542.23 | 181,990,864.14 | |
Total non-current liabilities | 9,718,729,800.88 | 4,499,548,959.98 | |
Total liabilities | 45,412,230,693.41 | 44,750,259,812.11 | |
- 10 -
Balance Sheet of the Company as at 30 September 2019 (continued)
(All amounts in RMB unless otherwise stated)
Items
Owners' equity (or shareholders' equity):
Paid -in capital (or share capital) Capital surplus
Less: treasury shares held for share incentive scheme Other comprehensive income
Surplus reserve Undistributed profits
Total owners' equity (or shareholders' equity)
Total liabilities and owners' equity (or shareholders' equity)
As at 30 September | As at |
2019 | 31 December 2018 |
2,971,656,191.00 2,971,656,191.00
20,994,494,034.83 20,988,670,493.54
135,317,558.39 135,317,558.39
5,088,075.475,863,991.89
1,072,928,171.82 1,072,928,171.82
1,240,274,831.64 1,832,220,909.86
26,149,123,746.37 26,736,022,199.72
71,561,354,439.78 71,486,282,011.83
- 11 -
Income Statement of the Company for the Nine Months Ended 30 September 2019
(All amounts in RMB unless otherwise stated)
Items
- Total operating revenue Including: Operating revenue
-
Total operating cost Including: Operating cost
Taxes and surcharges
Selling and distribution expenses General and administrative expenses Research and development expenses Financial expenses
Add: Other gains (loss shall be stated as "-")
Investment income (loss shall be stated as "-") Profit arising from changes in fair value (loss
shall be stated as "-")
Credit impairment losses (loss shall be stated as "-")
Asset impairment losses (loss shall be stated as "-")
Gains on disposal of assets (loss shall be stated as "-") -
Operating profit (loss shall be stated as "-")
Add: Non-operating income
Less: Non-operating expenses - Total profit (total loss shall be stated as "-")
Less: Income tax expenses - Net profit (net loss shall be stated as "-")
Classification according to the continuity of operation
For the nine | For the nine |
months ended | months ended |
30 September 2019 | 30 September 2018 |
12,182,565,592.96 10,380,476,076.53
12,182,565,592.96 10,380,476,076.53
12,251,129,947.07 10,462,860,360.36
11,559,271,920.07 9,798,453,409.36
21,129,024.7517,737,071.21
187,318,166.03 144,286,377.17
287,441,371.64 186,941,176.60
- | - |
195,969,464.58 315,442,326.02
22,749,391.8542,251,984.39
1,205,039,897.64 1,031,503,415.85
3,779,561.5841,314,500.49
(10,425,755.06) (11,370,619.85)
12,644,215.427,037,997.18
- | - |
1,165,222,957.32 1,028,352,994.23
203,547.0928,673.76
145,064.452,574,630.91
1,165,281,439.96 1,025,807,037.08
3,950,365.494,455,516.03
1,161,331,074.47 1,021,351,521.05
Net profit from continuing operations | 1,161,331,074.47 | 1,021,351,521.05 |
Net profit from discontinued operations | - | - |
- 12 -
Income Statement of the Company for the Nine Months Ended 30 September 2019 (continued)
(All amounts in RMB unless otherwise stated)
For the nine | For the nine | ||
months ended | months ended | ||
Items | 30 September 2019 | 30 September 2018 | |
6. | Other comprehensive income/(loss), net of tax | (775,916.42) | (1,564,027.97) |
Other comprehensive income/(loss) that will not be | |||
reclassified to profit or loss in subsequent periods | - | - | |
Other comprehensive income/(loss) that may be | |||
reclassified to profit or loss in subsequent periods | (775,916.42) | (1,564,027.97) | |
Other comprehensive income using the equity method | |||
that may be reclassified to profit or loss | (775,916.42) | (1,564,027.97) | |
7. | Total comprehensive income | 1,160,555,158.05 | 1,019,787,493.08 |
- 13 -
Cash Flow Statement of the Company for the Nine Months Ended 30 September 2019
(All amounts in RMB unless otherwise stated)
Items
1. Cash flows from operating activities:
Cash received from sales of goods or rendering of services Refund of taxes and surcharges
Cash received relating to other operating activities
Sub-total of cash inflows from operating activities
Cash paid for goods and services
Cash paid to and on behalf of employees Payments of taxes and surcharges
Cash paid relating to other operating activities
For the nine months ended 30 September 2019
12,636,019,211.46
-
619,676,223.88
13,255,695,435.34
13,141,199,405.07
212,571,500.38
155,689,746.86
688,552,642.90
For the nine
months ended 30 September 2018
11,255,430,893.43
41,459,118.88
648,719,265.48
11,945,609,277.79
11,492,315,029.82
224,219,871.59
113,518,378.99
592,585,476.61
Sub-total of cash outflows from operating activities | 14,198,013,295.21 | 12,422,638,757.01 | ||
Net cash flows used in operating activities | (942,317,859.87) | (477,029,479.22) | ||
2. | Cash flows from investing activities: | |||
Cash received from disposal of investments Cash received from returns on investments
Net cash received from disposals of fixed assets, intangible assets and other long-term assets
Net cash received from disposal of subsidiaries and other business units
Cash received relating to other investing activities
Sub-total of cash inflows from investing activities
Cash paid to acquire fixed assets, intangible assets and other long-term assets
Cash paid to acquire investments
Cash paid relating to other investing activities
Sub-total of cash outflows from investing activities
65,453,503.8858,333,485.68
1,019,279,987.76 1,038,268,309.12
-44,775.60
(1,472,447.32)-
2,121,953,511.88637,142,899.78
3,205,214,556.20 1,733,789,470.18
41,342,820.51 1,341,851,645.94
693,162,622.40 1,223,942,400.00
8,069,140,963.44 7,627,225,524.56
8,803,646,406.35 10,193,019,570.50
Net cash flows used in investing activities | (5,598,431,850.15) | (8,459,230,100.32) | |
- 14 -
Cash Flow Statement of the Company for the Nine Months Ended 30 September 2019 (continued)
(All amounts in RMB unless otherwise stated)
For the nine | For the nine | ||
months ended | months ended | ||
Items | 30 September 2019 | 30 September 2018 | |
3. Cash flows from financing activities: | |||
Cash received from borrowings | 28,773,134,783.19 | 27,679,365,800.00 | |
Cash received relating to other financing activities | 210,692,714,773.14 | 165,889,989,156.53 | |
Sub-total of cash inflows from financing activities | 239,465,849,556.33 | 193,569,354,956.53 | |
Cash repayments of borrowings | 22,665,355,483.19 | 17,529,990,011.50 | |
Cash payments for interest expenses and distribution of | |||
dividends or profits | 2,279,444,693.88 | 2,268,608,027.15 | |
Cash payments relating to other financing activities | 216,950,174,850.13 | 169,442,678,495.71 | |
Sub-total of cash outflows from financing activities | 241,894,975,027.20 | 189,241,276,534.36 | |
Net cash flows (used in)/from financing activities | (2,429,125,470.87) | 4,328,078,422.17 | |
4. Effect of foreign exchange rate changes on cash | |||
and cash equivalents | 1,035,214.53 | 1,791,989.90 | |
5. Net decrease in cash and cash equivalents | (8,968,839,966.36) | (4,606,389,167.47) | |
Add: Cash and cash equivalents at the beginning of the | |||
reporting period | 14,688,606,790.90 | 9,680,575,167.32 | |
6. Cash and cash equivalents at the end of the reporting | |||
period | 5,719,766,824.54 | 5,074,185,999.85 | |
By order of the Board
Sinopharm Group Co. Ltd.
Li Zhiming
Chairman
Shanghai, the PRC
25 October 2019
As at the date of this announcement, the executive directors of the Company are Mr. Li Zhiming, Mr. Yu Qingming and Mr. Liu Yong; the non-executive directors of the Company are Mr. Chen Qiyu, Mr. Ma Ping, Mr. Hu Jianwei, Mr. Deng Jindong, Mr. Wen Deyong, Ms. Guan Xiaohui and Ms. Dai Kun; and the independent non-executive directors of the Company are Mr. Yu Tze Shan Hailson, Mr. Tan Wee Seng, Mr. Liu Zhengdong, Mr. Zhuo Fumin and Mr.Chen Fangruo.
- The Company is registered as a non-Hong Kong company under the Hong Kong Companies Ordinance under its Chinese name and the English name "Sinopharm Group Co. Ltd."
- 15 -
Attachments
- Original document
- Permalink
Disclaimer
Sinopharm Group Co. Ltd. published this content on 28 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 October 2019 00:06:03 UTC